Bill Few Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Bill Few Associates's LLY Position: Q2 2026 in Review
Bill Few Associates reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $309K and leaving 1,850 shares worth $2.22M. The position accounts for 0.47% of the portfolio, ranked #54.
Bill Few Associates first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.39M in Q4 2025. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bill Few Associates held 1,850 shares of Eli Lilly worth $2.22M as of Q2 2026.
- Bill Few Associates sold 302 Eli Lilly shares in Q2 2026, an estimated $309K.
- Eli Lilly made up 0.47% of Bill Few Associates's portfolio in Q2 2026, its #54 holding.
- Bill Few Associates first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Bill Few Associates's Eli Lilly position peaked at $2.39M in Q4 2025.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.